Stock Alert: Sonoma Pharmaceuticals More Than Doubles

Shares of Sonoma Pharmaceuticals, Inc. (SNOA) are surging over 100% on Friday morning. The pharma company has teamed up with Crown Laboratories to launch Microcyn technology-based anti-itch over-the-counter products.

SNOA is currently trading at $12.54, up $6.34 or 102.22%, on the Nasdaq.

Sonoma and Crown announce they have entered into a license and supply agreement for the exclusive rights to sell and market products for the OTC dermatological market in the US.

Crown plans to sell Sonoma's Microcyn technology dermal sprays and gels targeting itch and pain under Sarna brand.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Green Field Farms Dairy has recalled its Whole Chocolate Milk product as a laboratory analysis indicated that the product was not effectively pasteurized, the U.S. Food and Drug Administration announced. The recall involves 1,242 units of the Whole Chocolate Milk with an expiration date of September 29, 2021. General Motors will start replacing defective battery modules in Chevrolet Bolt EVs and EUVs with new modules. The replacement battery modules will be shipped to dealers as soon as mid-October, the automaker said in a statement. CVS Health is set to recruit qualified candidates to fill 25,000 clinical and retail jobs during a one-day national career event on Friday, September 24. This will enable CVS to meet the high demand for pharmacists, pharmacy technicians, nurses, and retail store associates to support flu season, COVID-19 vaccinations and testing.
Follow RTT